Montefiori DC - Search Results

1

Demographic factors that influence the neutralizing antibody response in recipients of recombinant HIV-1 gp120 vaccines.

Montefiori DC, Metch B, McElrath MJ, Self S, Weinhold KJ, Corey L; HIV Vaccine Trials Network. Montefiori DC, et al. J Infect Dis. 2004 Dec 1;190(11):1962-9. doi: 10.1086/425518. Epub 2004 Oct 28. J Infect Dis. 2004. PMID: 15529261

2

Studies of high doses of a human immunodeficiency virus type 1 recombinant glycoprotein 160 candidate vaccine in HIV type 1-seronegative humans. The AIDS Vaccine Clinical Trials Network.

Keefer MC, Graham BS, Belshe RB, Schwartz D, Corey L, Bolognesi DP, Stablein DM, Montefiori DC, McElrath MJ, Clements ML, et al. Keefer MC, et al. Among authors: montefiori dc. AIDS Res Hum Retroviruses. 1994 Dec;10(12):1713-23. doi: 10.1089/aid.1994.10.1713. AIDS Res Hum Retroviruses. 1994. PMID: 7888231 Clinical Trial.

3

Binding of human immunodeficiency virus type 1 to the C3b/C4b receptor CR1 (CD35) and red blood cells in the presence of envelope-specific antibodies and complement. National Institutes of Health AIDS Vaccine Clinical Trials Networks.

Montefiori DC, Graham BS, Zhou JY, Zhou JT, Ahearn JM. Montefiori DC, et al. J Infect Dis. 1994 Aug;170(2):429-32. doi: 10.1093/infdis/170.2.429. J Infect Dis. 1994. PMID: 8035031

4

Neutralizing and infection-enhancing antibody responses to human immunodeficiency virus type 1 in long-term nonprogressors.

Montefiori DC, Pantaleo G, Fink LM, Zhou JT, Zhou JY, Bilska M, Miralles GD, Fauci AS. Montefiori DC, et al. J Infect Dis. 1996 Jan;173(1):60-7. doi: 10.1093/infdis/173.1.60. J Infect Dis. 1996. PMID: 8537683

5

Human immunodeficiency virus type 1 infection despite prior immunization with a recombinant envelope vaccine regimen.

McElrath MJ, Corey L, Greenberg PD, Matthews TJ, Montefiori DC, Rowen L, Hood L, Mullins JI. McElrath MJ, et al. Among authors: montefiori dc. Proc Natl Acad Sci U S A. 1996 Apr 30;93(9):3972-7. doi: 10.1073/pnas.93.9.3972. Proc Natl Acad Sci U S A. 1996. PMID: 8633000 Free PMC article.

6

The V3 domain of SIVmac251 gp120 contains a linear neutralizing epitope.

Palker TJ, Muir AJ, Spragion DE, Staats HF, Langlois A, Montefiori DC. Palker TJ, et al. Among authors: montefiori dc. Virology. 1996 Oct 15;224(2):415-26. doi: 10.1006/viro.1996.0548. Virology. 1996. PMID: 8874502 Free article.

7

Antibody-mediated neutralization of primary isolates of human immunodeficiency virus type 1 in peripheral blood mononuclear cells is not affected by the initial activation state of the cells.

Zhou JY, Montefiori DC. Zhou JY, et al. Among authors: montefiori dc. J Virol. 1997 Mar;71(3):2512-7. doi: 10.1128/JVI.71.3.2512-2517.1997. J Virol. 1997. PMID: 9032392 Free PMC article.

8

Neutralizing antibody responses to human immunodeficiency virus type 1 in primary infection and long-term-nonprogressive infection.

Pilgrim AK, Pantaleo G, Cohen OJ, Fink LM, Zhou JY, Zhou JT, Bolognesi DP, Fauci AS, Montefiori DC. Pilgrim AK, et al. Among authors: montefiori dc. J Infect Dis. 1997 Oct;176(4):924-32. doi: 10.1086/516508. J Infect Dis. 1997. PMID: 9333150

9

Analysis of intercurrent human immunodeficiency virus type 1 infections in phase I and II trials of candidate AIDS vaccines. AIDS Vaccine Evaluation Group, and the Correlates of HIV Immune Protection Group.

Graham BS, McElrath MJ, Connor RI, Schwartz DH, Gorse GJ, Keefer MC, Mulligan MJ, Matthews TJ, Wolinsky SM, Montefiori DC, Vermund SH, Lambert JS, Corey L, Belshe RB, Dolin R, Wright PF, Korber BT, Wolff MC, Fast PE. Graham BS, et al. Among authors: montefiori dc. J Infect Dis. 1998 Feb;177(2):310-9. doi: 10.1086/514209. J Infect Dis. 1998. PMID: 9466516 Clinical Trial.

10

Induction of immune responses to HIV-1 by canarypox virus (ALVAC) HIV-1 and gp120 SF-2 recombinant vaccines in uninfected volunteers. NIAID AIDS Vaccine Evaluation Group.

Belshe RB, Gorse GJ, Mulligan MJ, Evans TG, Keefer MC, Excler JL, Duliege AM, Tartaglia J, Cox WI, McNamara J, Hwang KL, Bradney A, Montefiori D, Weinhold KJ. Belshe RB, et al. AIDS. 1998 Dec 24;12(18):2407-15. doi: 10.1097/00002030-199818000-00009. AIDS. 1998. PMID: 9875578 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

755 results

Search Page